Subcutaneous rituximab with recombinant human hyaluronidase in the treatment of non-Hodgkin lymphoma and chronic lymphocytic leukemia

Future Oncology, Ahead of Print.


from Cancer via ola Kala on Inoreader http://ift.tt/2EjhVhx
via IFTTT